Procaps Group S.A. (PROC)

Business: Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.

IPO Date: 30-Sep-2021

Founder, CEO & Chairman: Mr. Ruben Minski

Pres: Dr. Camilo Camacho

Listing: NASDAQ: PROC

Country: Luxembourg

Headquarters: Luxembourg City,

Website: https://www.procapsgroup.com

Market cap: $986.08 Mln

Revenue (TTM): $409.74 Mln

Earnings (TTM): $-54.89 Mln

Cash: $72.11 Mln

Total Debt: $0.00 Mln

Insider's Holding: 84.68%

Liquidity: Low

52 Week range: $6.50 - 11.98

Shares outstanding: 112,824,000